Mahamaya Lifesciences LimitedBSE: MAHALIFE

Mahamaya Lifesciences Limited Press Release May 20 2026

· Issued by Mahamaya Lifesciences Limited via BSE India

Filed with BSE · · 1 page · English

Summary by 6ix AI

Mahamaya Lifesciences Limited has announced a forthcoming Board meeting scheduled to discuss financial results and other matters. The meeting will focus on the audited standalone and consolidated financial results for the recently concluded financial year. Additionally, the company has confirmed that the trading window will remain closed until two days after the financial results are announced.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of Mahamaya Lifesciences Limited is scheduled to be held on Monday, May 25, 2026, interalia, to consider and approve the following agenda: 1. The Audited Standalone Financial Results of the Company for the half year and financial year ended 31.03.2026, along with the Audit Report thereon. 2. The Audited Consolidated Financial Results of the Company for the half year and financial year ended 31.03.2026, along with the Audit Report thereon.

Mahamaya Lifesciences Limited on 6ix

Earlier from Mahamaya Lifesciences

Later from Mahamaya Lifesciences

All Mahamaya Lifesciences news releases